Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. administers 294.9 mln doses of COVID-19 vaccines - CDC

05/30/2021 | 02:24pm EDT

May 30 (Reuters) - The United States has administered 294,928,850 doses of COVID-19 vaccines in the country as of Sunday morning and distributed 366,316,945 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 293,705,050 vaccine doses the CDC said had gone into arms by May 29 out of 366,314,625 doses delivered.

The agency said 167,733,972 people had received at least one dose while 135,087,319 people are fully vaccinated as of Sunday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech , as well as Johnson & Johnson's one-shot vaccine as of 6 a.m. ET (1000 GMT) on Sunday. (Reporting by Bhargav Acharya in Bengaluru; Editing by Lisa Shumaker)


ę Reuters 2021
All news about MODERNA, INC.
08/03MODERNA : U.S. administers 347.4 mln doses of COVID-19 vaccines - CDC
RE
08/03MODERNA : U.S. CDC Says Delivered 401,229,975 Doses Of Covid-19 Vaccine As Of Au..
RE
08/03MODERNA : Covid-19 3rd Wave - Federal Govt Declares Lagos, Akwa Ibom, Rivers, Ka..
AQ
08/03MODERNA : Respiratory Syncytial Virus Vaccine mRNA-1345 Receives FDA Fast-Track ..
MT
08/03Sanofi bets on mRNA vaccines beyond COVID in $3.2 billion Translate Bio deal
RE
08/03MODERNA : Receives FDA Fast Track Designation for Respiratory Syncytial Virus (R..
BU
08/03Sanofi bets on mRNA vaccines beyond COVID in $3.2 billion Translate Bio deal
RE
08/03Moderna Gets FDA Fast Track Designation for Respiratory Syncytial Virus Vacci..
DJ
08/03ASTRAZENECA : Sanwo-Olu - Lagos Recorded 4,300 Cases, 30 Fatalities in July
AQ
08/03MODERNA : Covid-19 - U.S. Delivers 4m Doses Moderna Vaccines to Nigeria to Comba..
AQ
More news
Financials (USD)
Sales 2021 19 117 M - -
Net income 2021 10 725 M - -
Net cash 2021 11 948 M - -
P/E ratio 2021 15,3x
Yield 2021 -
Capitalization 155 B 155 B -
EV / Sales 2021 7,49x
EV / Sales 2022 8,47x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 386,51 $
Average target price 187,80 $
Spread / Average Target -51,4%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.269.97%155 195
LONZA GROUP AG25.60%58 688
IQVIA HOLDINGS INC.39.52%47 386
CELLTRION, INC.-26.18%31 285
SEAGEN INC.-9.68%28 062
PHARMARON BEIJING CO., LTD.82.70%24 138